BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24657240)

  • 1. Back to the heart: the protective role of adiponectin.
    Caselli C; D'Amico A; Cabiati M; Prescimone T; Del Ry S; Giannessi D
    Pharmacol Res; 2014 Apr; 82():9-20. PubMed ID: 24657240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
    Matsuda M; Shimomura I
    Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk between adipose tissue and vasculature: role of adiponectin.
    Li FY; Cheng KK; Lam KS; Vanhoutte PM; Xu A
    Acta Physiol (Oxf); 2011 Sep; 203(1):167-80. PubMed ID: 21062420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
    Matsuda M; Shimomura I
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of adiponectin in cardiovascular disease.
    Shibata R; Murohara T; Ouchi N
    Curr Med Chem; 2012; 19(32):5459-66. PubMed ID: 22876923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic perspectives for adiponectin: an update.
    Li FY; Lam KS; Xu A
    Curr Med Chem; 2012; 19(32):5513-23. PubMed ID: 22876919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
    Gable DR; Hurel SJ; Humphries SE
    Atherosclerosis; 2006 Oct; 188(2):231-44. PubMed ID: 16581078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin: anti-inflammatory and cardioprotective effects.
    Villarreal-Molina MT; Antuna-Puente B
    Biochimie; 2012 Oct; 94(10):2143-9. PubMed ID: 22796520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin and cardiovascular health: an update.
    Hui X; Lam KS; Vanhoutte PM; Xu A
    Br J Pharmacol; 2012 Feb; 165(3):574-90. PubMed ID: 21457225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
    Achari AE; Jain SK
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin: from obesity to cardiovascular disease.
    Antoniades C; Antonopoulos AS; Tousoulis D; Stefanadis C
    Obes Rev; 2009 May; 10(3):269-79. PubMed ID: 19389061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin: merely a bystander or the missing link to cardiovascular disease?
    Hatzis G; Deftereos S; Tousoulis D; Bouras G; Giannopoulos G; Anatoliotakis N; Tsounis D; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):139-63. PubMed ID: 23470075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipokines and coronary vasomotor dysfunction.
    Knudson JD; Dick GM; Tune JD
    Exp Biol Med (Maywood); 2007 Jun; 232(6):727-36. PubMed ID: 17526764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C; Fu Y; Chung BH; Garvey WT
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin, obesity, and cardiovascular disease.
    Fasshauer M; Paschke R; Stumvoll M
    Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches.
    Siasos G; Tousoulis D; Kollia C; Oikonomou E; Siasou Z; Stefanadis C; Papavassiliou AG
    Curr Med Chem; 2012; 19(8):1193-209. PubMed ID: 22257055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between adiponectin, obesity and insulin resistance.
    Balsan GA; Vieira JL; Oliveira AM; Portal VL
    Rev Assoc Med Bras (1992); 2015; 61(1):72-80. PubMed ID: 25909213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different molecular signaling sustaining adiponectin action in breast cancer.
    Panno ML; Naimo GD; Spina E; Andò S; Mauro L
    Curr Opin Pharmacol; 2016 Dec; 31():1-7. PubMed ID: 27552697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.
    Xu A; Vanhoutte PM
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1231-40. PubMed ID: 22210749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory and anti-atherogenic properties of adiponectin.
    Ohashi K; Ouchi N; Matsuzawa Y
    Biochimie; 2012 Oct; 94(10):2137-42. PubMed ID: 22713764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.